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A B S T R A C T
Imatinib is a first generation tyrosine kinase inhibitor, which is used for the treatment of chronicmyeloid
leukemia. However, resistance to imatinib is an important problem. Different mechanisms have been
explained for imatinib resistance. In this study, we examined the roles of macromolecules in imatinib
resistance in K562 cells at the molecular level using Fourier Transform Infrared (FT-IR) spectroscopy. An
amount of 3mM imatinib resistant cells were generated by our group and named as K562/IMA-3 cells.
Changes in macromolecules in parental and resistant cells were studied by FT-IR spectroscopy. Imatinib
resistance caused changes, which indicated decreases in the level of glycogen and increases in the
membrane order. The amount of unsaturated lipids increased in the imatinib resistant cells indicating
lipid peroxidation. Imatinib resistance caused changes in the lipid/protein ratio. The relative protein
content increased with respect to nucleic acids indicating higher transcription and protein expression
and structural/organizational changes in the nucleus were evident as revealed by frequency changes in
the nucleic acid bands. Changes in the amide bands revealed changes in the proteome of the resistant
cells. Protein secondary structural changes indicated that the antiparallel beta sheet’s structure
increased, however the alpha helix structure, beta sheet structure, random coil structure and turns
decreased in the resistant cells. These results indicate that the FT-IR technique provides a suitable
method for analyzing drug resistance related structural changes in leukemia and other cancer types.
 2013 Elsevier Masson SAS. All rights reserved.1. Introduction
Reciprocal translocation between chromosomes 22 and 9
generates BCR/ABL oncogene, which is the main cause of chronic
myeloid leukemia. BCR/ABL inhibits differentiation and apoptosis
and induces cell growth and proliferation. Imatinib is the first
anticancer agent targeting BCR/ABL oncoprotein for the treatment of
chronicmyeloid leukemia (CML)patients. It binds toATPbinding site
of BCR/ABL oncoprotein and inhibits its kinase activity that results in
inhibition of leukemogenesis [1,2]. Although high rates of hemato-
logical and cytogenetical responses, resistance to imatinib is still the
main problem for successful treatment of CML. Different mecha-
nismswereexplained for imatinibresistance, suchasoverexpression
of BCR/ABL, changes in nucleotide sequence of ATP binding site of
BCR/ABL, inhibition of apoptosis, aberrant ceramidemetabolismand
overexpression of transporter genes [3–6].* Corresponding author. Tel.: +90 232 7507515; fax: +90 232 7507509.
** Corresponding author. Tel.: +90 232 750 6328; fax: +90 232 750 6196.
E-mail addresses: yusufbaran@iyte.edu.tr (Y. Baran), cagatayceylan@iyte.edu.tr
(C. Ceylan).
0753-3322/$ – see front matter  2013 Elsevier Masson SAS. All rights reserved.
http://dx.doi.org/10.1016/j.biopha.2012.12.001Fourier transform infrared spectroscopy is a method used to
monitor molecular changes in the analysis of biological systems.
The method allows for rapid, sensitive and non-destructive
method analysis of samples in any physical state [7,8]. The
spectral data can be analyzed with many different digital
manipulations, producing both qualitative and quantitative
information considering shifts in peak positions, changes in
bandwidths and band intensities to obtain structural and
functional information about the systems analyzed. The data
can be used for detection of changes in cellular components such as
lipids, proteins, carbohydrates and nucleic acids at the level and in
close vicinity of functional groups simultaneously [7,9].
Since an FT-IR spectrum is amolecular fingerprint of the studied
tissue or cells, the technique can be suitably used to follow the
changes specific for biological differentiation processes such as
disease processes duringwhichmetabolic changeswith alterations
in carbohydrate, lipid and protein profiles occur. Similarly, FT-IR
technique has been developed to be a valuable diagnostic tool to
analyze and detect changes at themolecular level in cancer [10,11].
In this study, we examined the possible roles of macromole-
cules in imatinib resistance by Fourier transform infrared
spectroscopy (FT-IR). For this purpose, imatinib resistance was
Fig. 1. The general FT-IR spectrum of K562 cells in 3660–940 cm–1 region.
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lecular changes in various types of cancers against different
anticancer drugs including nilotinib have been investigated using
FT-IR technique [12–14], this is the first detailed study investigat-
ing the changes between sensitive and 3mM imatinib resistant
K562/IMA-3 cells in terms of biochemical variations.
2. Materials and methods
2.1. Cell lines and culture conditions
K562 CML parental cells were obtained from the German
collection ofmicroorganisms and cell cultures (Germany). The cells
were cultured in RPMI-1640 growth medium (Biological Indus-
tries, Israel) containing 15% fetal bovine serum (Biological
Industries, Israel) and 1% penicillin-streptomycin (Biological
Industries, Israel) at 37 8C in 5% CO2. Medium was refreshed every
3 days. The cell suspension was taken from tissue culture flasks
into a sterile falcon tube and was centrifuged for 10 min at
1000 rpm. The supernatant was removed and the pellet was
washed with 2 ml of phosphate buffered saline (PBS). The cells
were recentrifuged at 1000 rpm for 10 min. The cells were
resuspended in 15 ml of RPMI-1640 medium and transferred into
sterile culture flasks.
2.2. Sample preparation for FT-IR spectroscopy
We used 5  106 cells grown in 15 ml of RPMI-1640 medium.
The cells were collected and dissolved in sterile distilled water.
The collected cells were lyophilized in a freeze drier (Labconco,
FreeZone 18 liter freeze dry system) overnight to remove water.
The cell powder was mixed with dried potassium bromide (KBr)
(Sigma-Aldrich, USA) in amortar (at a ratio of 1:100). Themixture
was then pressurized to 100 kg/cm2 (1200 psi) for 5 min. All the
cell growth, cell collection and FT-IR experiments for the imatinib
sensitive and resistant K562 cells were carried out on the same
day.
2.3. FT-IR spectrum accumulation and data processing
The spectral analysis was carried out using a PerkinElmer
spectrometer equipped with MIR TGS detector (Spectrum 100
Instrument, PerkinElmer Inc., Norwalk, CT, USA). FT-IR spectra of
the samples were recorded between 4000 and 450 cm1. Inter-
ferograms were averaged for 20 scans at 4 cm1 resolution. The
background spectrum was automatically subtracted from the
spectra of the samples. Spectrum 100 software (PerkinElmer) was
used for all data manipulations.
From each sample, at least three different scans, which gave
identical spectra, were performed. These replicates (n = 7 for the
sensitive; n = 12 for the resistant cells) were averaged and the
averaged spectra for each sample were then used for further data
manipulation and statistical analysis. The spectra were
smoothed over 19 points using the Savitzky–Golay algorithm.
Then, the spectra were interactively baselined from two
arbitrarily selected points. Finally, the spectra were normalized
in specific regions for visual comparison of the imatinib sensitive
and resistant samples.
For determination of protein secondary structural changes, the
second derivative spectra were obtained by applying a Savitzky–
Golay algorithm with five points. The second derivatives were
normalized between 1700 and 1600 cm1 and the peak intensities
were calculated. The peak minima of the second derivative signals
were considered because they correspond to the peak minima of
the original absorption spectra [15].2.4. Statistical analysis
The differences between the imatinib-sensitive and resistant
groups were compared using the Mann–Whitney U Test with the
Matlab R2011a program. The statistical results are expressed as
means  standard deviation. P < 0.05 was considered statistically
significant.
3. Results
3.1. FT-IR studies
We previously reported that IC50 values of imatinib for K562
and K562/IMA-50 cells were found to be 280 and 14680 nM,
respectively. However, the results revealed that K562/IMA-3 cells
were much more resistant to imatinib as compared to K562 cells
[15].
The FT-IR spectroscopy technique is a technique, which
investigates biological systems at the molecular level and provides
information about the structure [7] and function of the macromo-
lecular constituents such as lipids, proteins and nucleic acids [9].
Hence, the technique was used in the analysis of the effects of
imatinib resistance on K562 cells in our studies.
Fig. 1 shows the average FT-IR spectra of control K562 cells in
the 3660–940 cm1 spectral region. Assignments of the major
bands in Fig. 1 are presented in Table 1. The FT-IR spectrumof K562
cells consists of several bands originating from the contribution of
different functional groups of macromolecules. The spectra were
analyzed for the following regions: 2820–3660 cm1 for the
analysis of proteins and lipids, and 1595–1775 cm1 for the
analysis of proteins and lipids, 940–1480 cm1 for the analysis of
the fingerprint region. All the spectra presented in the figures were
normalized with respect to specific selected bands and were used
only for illustrative purposes. However, in the measurement of the
spectral parameters, each original baseline-corrected spectrum
belonging to the corresponding control and treated groups was
considered separately.
3.2. 2820–3660 cm1 region
The average FT-IR spectra of the sensitive and K562/IMA-3 cells
in the 2820–3660 cm1 spectral region is shown in Fig. 2. The FT-IR
spectrum in this region consists of amide A and amide B bands
which have contributions from mainly the N–H stretching of
proteins with a small contribution from the O–H stretching of
polysaccharides and intermolecular H bonding and contributions
from C–N and N–H stretching of proteins, respectively. In addition,
the olefinic CH stretching vibration band located around
3011 cm1, which has contributions from cholesterol esters[(Fig._1)TD$FIG]
Table 1
The general FT-IR band assignments of K562 cells.
Band number Wave numbers (cm–1) Definition of the spectral assignment
1 3300 Amide A: mainly N–H stretching of proteins with the little contribution from O–H stretching of polysaccharides and
intermolecular bonding
2 3061 Amide B: C–N and N–H stretching of proteins
3 3011 Olefinic CH stretching vibration: unsaturated lipids, cholesteryl esters
4 2959 CH3 asymmetric stretching: lipids, protein side chains, with some contribution from proteins, carbohydrates
5 2925 CH2 asymmetric stretching: mainly lipids, and the little contribution from proteins and carbohydrates
6 2873 CH3 symmetric stretching: protein side chains, lipids and with some contribution from carbohydrates and
nucleic acids.
7 2854 CH2 symmetric stretching: mainly lipids, with the little contribution from proteins, nucleic acids and carbohydrates
8 1743 Ester C O stretching: triglycerides and cholesterol esters
9 1657 Amide I: proteins, mainly C O stretch
10 1546 Amide II: proteins, mainly N–H bend and C–N stretch
11 1452 CH2 bending: mainly lipids, with the little contribution from proteins, CH3 asymmetric bending: methyl groups of
proteins
12 1399 COO– symmetric stretch: mainly lipids with the little contribution from proteins; CH3 symmetric bending: methyl
groups of proteins
13 1239 PO2
– asymmetric stretch: mainly nucleic acids with the little contribution from phospholipids
14 1086 PO2
– symmetric stretch: nucleic acids and phospholipids; C–O stretch: glycogen
15 971 C–N+–C stretch: nucleic acids
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1
has contributions from both lipids and proteins; the CH2
asymmetric stretching band located at 2925 cm1 is mainly due
to lipids; the CH3 symmetric stretching band located at 2873 cm
1
is mainly due to protein side chains with some contribution from
lipids, carbohydrates and nucleic acids and CH2 symmetric
stretching band located at 2854 cm1 monitors mainly lipids,
with small contributions from proteins, nucleic acids and
carbohydrates [8,17].
Imatinib resistance induced remarkable changes in the
bandwidth, intensity and frequency value of the FT-IR bands in
this region as seen from Fig. 2. Comparisons of the band intensities
of some infrared bands of imatinib sensitive and resistant K562
cells are shown in Fig. 3. As can be seen from Fig. 2, there was a
reduction in the intensity of amide A band which is located at
3300 cm1, however the intensity of the amide B band which is
located at 3061 cm1 was increased amide B band contains strong
absorptions arising mainly from C–N and N–H stretching of
proteins mode of proteins and of K562 cells. When normalized
with the intensity of the amide I band, 9.80% reduction was
observed for imatinib resistant cells for amide A band as seen in
Fig. 3. The frequency of the amide A band shifted from
3300.12  0.720 to 3300.443  0.351 cm1 in K562/IMA-3 cells only
slightly (P = 0.5826). However, the frequency of the amide B band
[(Fig._2)TD$FIG]Fig. 2. The FT-IR spectra of imatinib sensitive (solid line) and resistant (dotted line)
cells in the 3660–2820 cm–1 region (the spectra were normalized with respect to
CH2 asymmetric mode, which is observed at 2925 cm
–1).shifted from 3061.315  1.084 to 3061.444  1.274 cm1 in imatinib
resistant K562 cells [16,18–20].
The absorptions arising from C–H stretching vibrations of
aliphatic compounds is populated between 3000 cm1 and
2820 cm1 as shown in Fig. 4. When normalized to the band at
2925 cm1, the intensity of the CH3 asymmetric band at 2959 cm
1
and CH3 symmetric stretch band at 2872 cm
1 decreased for K562/
IMA-3 cells, whereas the intensity of the CH2 symmetric stretch
band at 2854 cm1 increased slightly for K562/IMA-3 cells. In Fig. 3
the intensity ratio of 2874 cm1 and 2852 cm1 decreased by
5.043% in K562/IMA-3 cells (P < 0.0001). The frequency of the CH3
asymmetric stretch band around 2959 cm1 band shifted from
2959.213  0.136 to 2958.680  0.105 cm1 (P < 0.005) and the
frequency of CH3 symmetric stretching band located around
2873 cm1 shifted from 2873.255  0.078 to 2872.435  0.056
(P < 0.005) in K562/IMA-3 cells.
The intensity of the band at 3011 cm1 increased 4.82 fold in
K562/IMA-3 cells. Since this band is due to the CH stretching of
HC CH groups, it can be said that the degree of unsaturation
increases in the imatinib resistant cells.
3.3. 1595–1775 cm1 region
The average FT-IR spectra of the sensitive and K562/IMA-3 cells
in the 1775–1595 cm1 spectral region is shown in Fig. 5. The band
centered at 1743 cm1 is mainly assigned to the C O ester
stretching vibration of triglycerides and cholesterol esters
[7,21,22]. As seen in Fig. 5, the intensity and frequency of the
C O ester stretching vibration increased for K562/IMA-3 cells. The
bands at 1657 cm-1 and 1546 cm-1 are amide I and amide II bands
of proteins. Both of them are known to be sensitive to protein
conformation and are used to determine the secondary structure
content of proteins. Changes in the shapes of these two bands
indicated changes in the proteomes of the imatinib resistant cells.
In Fig. 3 the ratio of the intensities of Amide I/Amide II bands
increased (3.65%) for K562/IMA-3 cells [7].
In addition, the secondary derivative of the Amid I band showed
changes in the alpha helix band around 1656 cm1 and loss of
random coil band around 1648 cm1 for K562/IMA-3 cells as seen
in Fig. 6 The assignments of the secondary structural components
and the intensities of the sub-bands are given in Tables 2 and 3,
respectively. The results revealed that the antiparallel beta sheet
structure increased slightly, however, the alpha helical structure
(located at 1653 cm1), random coil structure (located at
[(Fig._3)TD$FIG]
Fig. 3. The intensity-ratio values of the bands for imatinib sensitive and resistant K562 cells. The values are the mean  standard deviation for each group.
[(Fig._4)TD$FIG]
Fig. 4. The FT-IR spectra of imatinib sensitive (solid line) and resistant (dotted line)
cells in the 3000–2820 cm–1 region (the spectra were normalized with respect to
CH2 asymmetric mode, which is observed at 2925 cm
–1).
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the turns (located at 1674 cm1) decreased slightly in the imatinib
resistant cells (P < 0,05).
3.4. 940–1480 cm1 (fingerprint) region
The average FT-IR spectra of the imatinib sensitive and resistant
K562 cells in the 940–1480 cm1 spectral region is shown in[(Fig._5)TD$FIG]Fig. 5. The FT-IR spectra of imatinib sensitive (solid line) and resistant (dotted line)
cells in the 1775–1595 cm–1 region (the spectra were normalized with respect to
amide I band, which is observed at 1657 cm–1).Fig. 7A–C. The band at 1452 cm1 is attributed to CH2 bending
vibration of lipids [23,24]. The frequency of the band
around 1453 cm1 shifted from 1452.951  0.451 to
1454.56  0.266 cm1 in K562/IMA-3 cells as seen in Fig. 7A
(P < 0.005). The band at 1399 cm1 is attributed to COO
symmetric stretch of mainly lipids with a small contribution from
proteins (Jackson et al., 1998) The frequency of the band around
1399 cm1 shifted from 1399.503  0,319 to 1400  0.311 cm1
(P < 0.005). The bands at 1239 and 1086 cm1 are of nucleic acids
and attributed to PO2
 asymmetric and symmetric stretch [25,26].
The frequency of the band around 1085 cm1 band shifted from
1086.00  0.338 to 1086.637  0.037 cm1 in K562/IMA-3 cells
(P < 0.005) as in Fig. 7C. The band at 1155 cm1 is attributed to C–O
stretching of glycogen [27]. A notable decrease in the intensity of
this band was observed in the K562/IMA-3 cells as seen in Fig. 7B.
The band at 970 cm1 is assigned to C–N+–C stretch of nucleic acids
[28].
In the analysis of the bands in this region the intensity ratio of
the 1030 cm1 and 1080 cm1 bands decreased by 12.90% in K562/
IMA-3 cells (P < 0.005) as seen in Fig. 3. Similarly, in the same
figure the intensity ratio of 1030 cm1 and 2926 cm1 bands
decreased by 22.04% (P < 0.005); 1080 cm1 and Amide II bands
increased by 2.78% (P < 0.005) and 1121 cm1 and Amide II bands
decreased by 4.08% (P = 0.1391) in K562/IMA-3 cells. However, a
considerable increase (19.79%) in the intensity ratio of the
1121 cm1 and 1020 cm1 bands was observed in K562/IMA-3
cells (P < 0.005) as seen in Fig. 3.[(Fig._6)TD$FIG]
Fig. 6. The average second derivative spectra of imatinib sensitive (solid line) and
resistant (dotted line) K562 cells in 1700–1600 cm–1 region.
[(Fig._7)TD$FIG]
Fig. 7. The FT-IR spectra of imatinib sensitive (solid line) and resistant (dotted line)
cells (a) in the 1480–1430 cm–1 region (the spectrawere normalizedwith respect to
CH2 bending mode, which is observed at 1452 cm
–1); b: in the 1184–1145 cm–1
region; c: in the 1350–940 cm–1 region (the spectra were normalized with respect
to PO2
– symmetric stretching mode, which is observed at 1086 cm–1).
Table 2
The assignments of secondary structure sub-bands under amide I band in 1700–
1600 cm–1 region for imatinib sensitive and resistant K562 cells [15].
Peak number Mean frequencies (cm–1) Assignment
1 1694 Antiparallel beta sheet
2 1674 Turns
3 1653 Alpha helix
4 1648 Random coil
5 1637 Beta sheet
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Targeting the tyrosine kinase activity of BCR-ABL is a common
and attractive therapeutic strategy for effective treatment of
chronic myeloid leukemia. Imatinib is a very effective tyrosine
kinase inhibitor, which gives positive results in first line treatment
of CML patients. Unfortunately, CML cells can somehow escape
from the apoptotic effects of imatinib and acquire resistance. This
is the most important problem in the clinic to get successful
results. The molecular mechanisms of multidrug resistance in CML
were shown by our group and other researchers [3,4,29]. However,
changes in macromolecular levels in imatinib resistant CML cells
and the roles of these differences on imatinib resistance were not
examined and discussed in the literature. In this study, we
investigated the changes in macromolecular structures in imatinib
resistant CML cells by using FT-IR and compared the results with
the sensitive cells.
In the preparation of the samples, water was removed from the
samples in the sample preparation steps using lyophilization
procedures in this study. Hence, contribution from water to Amid
A, Amid B, Amid I and Amid II bands was negligible. For this reason,
the 3300 cm1 band can be considered to be due to only proteins
and polysaccharides. The reduction in the intensity ratios of Amid
A to Amid I in the imatinib resistant cells can be due to the reduced
contribution of glycogen since a decrease was observed in the
intensity of the 1155 cm1 bandwhich ismainly assigned to the C–
O stretching vibrations of glycogen [27]. Since cancer cells are
known to consume more carbohydrate due to their increased
energy expenditure which is known as the Warburg Effect. The
reduction in the intensity of these two bands could be ascribed to
reduce contribution of polysaccharides in the resistant cells [30].
Similarly, drug resistance is hypothesized to require more energy
for the additional tasks of elimination of toxic compounds and
drugs.
The intensity of the band at 3015 cm1 which is due to CH
stretching of olefinic HC CH stretching vibrations indicates that
the population of unsaturated lipids increased in the resistant cells.
In addition, the increase in the olefinic band may be due to the
accumulation of end products of lipid peroxidation and a change in
phospholipid metabolism [31]. The increase in the level of
unsaturation was found to be 4.82 times higher than that of the
sensitive cells. It appears that drug resistant cells have better
resistance to reactive oxygen species such as peroxides. This
conclusion is supported by the results obtained from the bands
around 1743 cm1. The change in shape and frequency of the band
around 1743 cm1 indicated the changes in the ratio of triglycer-
ides and cholesterol esters and their saturation states, it is seen
that in K562/IMA-3 cells, themaximumof the band shifts to higher
frequency values and the intensity also increases at around
1743 cm1 in Fig. 5 and it is known that packing of ester groups in
the constituent fatty acids is strongly dependent on their
saturation state.
The decrease in CH3 asymmetric stretching vibration absorp-
tion intensity in the imatinib resistant cells indicates a change in
the composition of the acyl chains in lipids as shown in Fig. 2 [32].In addition, the frequency of the CH3 asymmetric stretch band
shifted from 2959.213 to 2958.68 cm1 in K562/IMA-3 cells. The
decrease in the frequency corresponds to decreasing freedom of
the acyl chain in the center of the bilayer since the CH3 asymmetric
stretching mode is correlated with the order of the deep interior of
the membrane [17]. Hence, the order in the lipid plasma
membrane interior is increased in the resistant cancer cells [33].
In addition, the intensity of the CH2 symmetric stretching band
decreased in the resistant cells indicating a decreasing proportion
Table 3
The results of the changes in the intensities of main protein secondary structures for imatinib sensitive and resistant K562 cells.
Functional groups Sensitive Resistant P values
Antiparallel beta sheet structure (located at 1694cm–1) –0.012490.00135 –0.0133 0.00301 P<0,05
Turns (located at 1674cm–1) –0.010270.002127 –0.00945 0.002147 P<0,05
Alpha helical structure (located at 1653cm–1) –0.01340.01082 –0.01082 0.002363 P<0,05
Random coil structure (located at 1648cm–1) –0.014870.002246 –0.00915 0.002431 P<0,05
Beta sheet structure (located at 1637cm–1) –0.013710.002187 –0.01045 0.00098 P<0,05
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the bending vibration at 1452 cm1 shifted from 1452.95 to
1454.56 cm1 in K562/IMA-3 cells indicating changes in the lateral
packing property of the methylene groups in the membrane lipids
[34].
A precise protein-to-lipid ratio can be derived by calculating the
intensity ratio of the CH3 symmetric stretching (2874 cm
1) to the
CH2 symmetric stretching vibration (2852 cm
1) from the FT-IR
spectra [7]. The intensity ratio of 2874 cm1 and 2852 cm1 was
found to decrease by 5.04% in K562/IMA-3 cells. These results
indicate an increase in the lipid content of the cellular material for
constant protein content. Although there have been contrasting
reports of the change in the amount of lipids in drug resistant cells,
in general lipidation is considered to be one of the general response
of the cell to toxic environments [35,36].
Amide I band frequency and shape is sensitive to protein
conformation. Thechanges in theshapeof theAmide Ibandasseen in
Fig. 5 are attributed to the changes in protein conformation [37]. In
addition, the intensity ratioofAmide I/Amide IIwas found to increase
3.80% for K562/IMA-3 cells indicating protein secondary structural
changes. Although this ratio was ascribed to the changes in only
membrane proteins by Zhou et al. in HL60 cells that underwent
apoptosis, in this study it describes a total change in the proteome
and protein structural changes of that proteome [38]. Protein kinase
inhibitors can change the cellularmetabolism considerably. As toxic
drugs theycan initiateendoplasmic reticulumstress responsevia the
expressionof proteins such as chaperones andheat shockproteins to
alleviate the adverse effects [39]. The proteome of the resistant cells
change as a result. In another study investigating doxorubicin
resistance observed an increase in the band around 1690 cm1
(antiparallel beta sheets) similar to our results [13].
The nucleic acid bands appear at 1239 cm1, 1086 cm1 and
971 cm1. The 1239 cm1 band is due to asymmetric phosphate
stretching and the 1086 cm1 band is due to symmetric phosphate
stretching band of nucleic acids [25,26]. The band at 970 cm1 is
due to C-N+-C stretching of nucleic acids [27]. The frequency of the
asymmetric stretching band was shifted to higher frequency
values in imatinib resistant cells. In addition, the changes in the
intensities of the bands at 1239 and 970 cm1 for the imatinib
resistant cells indicate structural changes in nuclear morphology,
organization, and architecture such as alterations in the nuclear/
cytoplasmic ratio, hyperchromacity, chromatin aggregation and
changes in DNA condensation between imatinib sensitive and
resistant K562 cells. Multidrug resistance was linked to specific
nuclearmorphological changes acquired in the process of selection
by cytotoxic drugs rather than P-gp overexpression or changes in
the expression level of topoisomerase II beta [39,40].
The intensity ratio of the 1086 cm1 band is due to symmetric
phosphate stretching of nucleic acids and the Amide II band at
1545 cm 1 is used to estimate DNA/protein ratio in the cellular
systems investigated [41]. In this study, the intensity ratio of
1080 cm1 and Amide II bands decreased by 7.21% in K562/IMA-3
cells indicating a small decrease in the DNA over protein amount.
This ratio was observed to increase in differentiated and apoptotic
cells [38] and in chronic lymphatic leukemia cells during cellular
differentiation [42].The intensity ratio of the 1030 cm1 and 1086 cm1 bands
indicates glucose/phosphate ratio as a reliable measure for
metabolic turnover of the cells. The glucose/phosphate ratio was
found to decrease by 12.90% in K562/IMA-3 cells. The phosphate
level was higher for normal cells than for H-ras transfected
malignant cells in earlier studies. Similarly, the intensity ratio of
1030 cm1 and 2926 cm1 bands was found to decrease by 22.03%
in K562/IMA-3 cells. This ratio is indicative of the ratio of glucose/
phospholipids and is a measure of de novo synthesis of
phospholipids at the expense of free glucose in the cell and was
found to be larger for normal cells as compared to those
transformed by H-ras [43]. Decreases in both the ratios indicate
an increase in the total amount of phosphate compounds in the
imatinib resistant cancer cells. In cancer cell formation, the
phospholipid molecules and their metabolites are believed to
participate in the oncogene-induced transformation processes [44]
and protein phosphorylation is known to be fostered [45]. These
results also agree with the increase in the intensity of the shoulder
around 1170 cm1 in the imatinib resistant cancer cells indicating
protein phosphorylation [46]. Gazi et al. suggested that the
intensity ratio of the 1030 cm1 and 1086 cm1 bands could be
interpreted as glycogen-to-phosphate ratio and proposed as a
marker for cancer to distinguish benign and malignant prostate
cancer and they concluded that the ratio decreased in malignant
tissue [47].
The intensity ratio of the 1121 cm1 and 1020 cm1 bands was
observed to increase (19.78%) in K562/IMA-3 cells. This ratio is
indicative of cellular RNA/DNA ratio and is found to increase from
normal to malignant cells [43]. This ratio was found to increase
similar to malignant transformation. The increase in the RNA
content with respect to the DNA content indicates higher necessity
of transcription to deal with the toxic drug effects. Similarly, the
intensity ratio of the 1121 cm1 and Amide II bands decreased by
4.03% in K562/IMA-3 cells. This ratio is indicative of the
transcriptional and protein expression status of the imatinib
resistant cancer cells. The results indicate that the protein
expression status of the K562/IMA-3 cells increases.
Different mechanisms cause drug resistance in different cancer
types. In addition, a number of different drugs are used in cancer
therapy many of which have been known to induce drug
resistance. Hence, comprehensive molecular and spectroscopic
studies should be carried out to make general conclusions about
the onset and progress of resistance behavior of cancer cells against
these drugs.
The results of the present study indicate that the induction of
imatinib resistance in K562 cells caused alterations in cellular
structure. The content of glycogen was found to decrease in the
K562/IMA-3 cells. The amount of unsaturated lipids increased in
the imatinib resistant cells indicating lipid peroxidation. In
addition, lipid membrane order was found to increase in the
K562/IMA-3 cells. Imatinib resistance caused changes in the lipid/
protein ratio in the imatinib resistant cancer cells indicating
possible changes in neutral lipid and lipid droplet metabolism as
well as phospholipid metabolism which affect cell membrane
structure. The relative content of proteins with respect to nucleic
acids indicates higher transcription and protein expression and
Y. Baran et al. / Biomedicine & Pharmacotherapy 67 (2013) 221–227 227structural/organizational changes in the nucleus as revealed by
frequency changes in the nucleic acid bands. Changes in the amide
bands revealed changes in the proteome of the resistant cells. The
antiparallel beta sheet structure increased, however the other
secondary structural elements decreased in the resistant cells. The
results of the present study also revealed that FT-IR spectroscopy
has the potential to be used as an analytical method of detecting
andmonitoringmacromolecular structural and functional changes
in drug resistant CML.
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